Indefinite Delivery Contract 36C26325D0021
Award Date
1/15/25
Last Date to Order
1/14/28
Federal Agency
Veterans Integrated Service Network 23
Awardee
Caredx, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for LAB TESTS FOR POST TRANSPLANT CARE, issued by the Department of Veterans Affairs (VA) to the prime contractor Caredx, Inc., a for-profit medical diagnostics company based in Brisbane, California. This is a single-award Indefinite Delivery Contract valued at $4,367,680.42 with a period of performance from April 1, 2025 to March 31, 2030. The contract aims to procure a range of specialized genetic and molecular testing services from Caredx, including the...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded an Indefinite Delivery Contract (IDC) to Caredx, Inc., a for-profit organization, to provide AlloSure kidney testing kits and related services to support the VA's transplant programs. The initial IDC award, valued at $1,420,375, was made in September 2021 as a total small business set-aside. Under this contract, the VA has subsequently issued multiple delivery orders for AlloSure kidney testing, with individual...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Caredx, Inc., a for-profit medical technology company specializing in advanced diagnostic solutions for organ transplant patients. The contract, valued at $1,963,141.20, is for the provision of genetic blood testing services, specifically the AlloMap and AlloSure testing products, to support the VA's transplant programs across multiple Veterans Integrated Service Networks (VISNs). The...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 17 awarded a single-award indefinite delivery contract to Caredx Lab Solutions Inc., a subsidiary of Caredx Inc., to provide AlloMap molecular testing services for heart transplant recipients. The $675,000 IDC, which runs through June 2027 with no set-aside, establishes Caredx as the sole supplier of the FDA-approved AlloMap test to aid in post-transplant surveillance and...
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
The federal contract IDV award is held by Cepheid, a for-profit manufacturer of molecular diagnostic solutions including tests for infectious diseases and genetic conditions. The contract, valued at a ceiling of $14,608,507.24, is with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 for the procurement of Cepheid reagents and test kits. This single-award indefinite delivery contract enables the VA to continuously obtain Cepheid's molecular diagnostic products to...
This federal contract Indefinite Delivery Vehicle (IDV) is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) to Mdxhealth, Inc., a for-profit healthcare company based in Irvine, California. The contract, valued at up to $755,655.00, is for the provision of prostate cancer testing services under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The BPA has a period of performance from July 1, 2022 through...
This indefinite delivery contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 23 to Veracyte, Inc., a for-profit medical diagnostics company. The contract, which is not set aside for any specific business category, has a ceiling value of $2,000,000 and an ultimate completion date of April 30, 2028. Under this contract, Veracyte will provide reference laboratory services, including specialized genomic testing and classifier services, to support...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The IDV, valued at up to $3,000,000, is for the procurement of Cepheid's XPERT MRSA, FLU, and COVID-19 test kits compatible with the VA's existing GeneXpert analyzers. The contract has no set-aside designation and is a single award. Delivery orders have been issued...
The federal contract IDV award is for Decipher Prostate Genomic Classifier testing services provided by Veracyte Labs SD Corporation, a division of Veracyte, Inc., to the Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract has a ceiling value of $194,435.40 and a period of performance through September 30, 2026. Under this IDV, Veracyte will deliver task orders for Decipher Prostate Cancer testing to support the VA's efforts to provide personalized cancer care...